MannKind | MNKD - EPS Earnings Per Share


MannKind reported $0.07 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.01 0.08 Feb/26 2026
FY2025Q3 Sep/2025 0.07 0.02 0.06 Nov/05 2025
FY2025Q2 Jun/2025 0.05 0.05 0.05 Aug/06 2025
FY2025Q1 Mar/2025 0.07 0.03 0.04 May/08 2025
FY2024Q4 Dec/2024 0.08 0.03 0.02 Feb/26 2025




Eps Change Date
Adma Biologics USD 0.15 0.01 Sep/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Eli Lilly USD 7.54 0.52 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 0.27 0.84 Sep/2025
MannKind USD 0.07 0.02 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD -0.76 1.76 Sep/2024
Novo Nordisk DKK 1.02 0.1 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Sanofi EUR 1.53 1.38 Dec/2025
Xencor USD -0.08 0.33 Sep/2025